Natural Product (NP) Details
General Information of the NP (ID: NP1709) | |||||
---|---|---|---|---|---|
Name |
Salvianolic acid A
|
||||
Synonyms |
Salvianolic acid A; 96574-01-5; (R)-3-(3,4-Dihydroxyphenyl)-2-(((E)-3-(2-((E)-3,4-dihydroxystyryl)-3,4-dihydroxyphenyl)acryloyl)oxy)propanoic acid; Salvianolic-acid-A; SALVIANOLIC ACID; CHEMBL457077; UNII-51622542XO; CHEBI:9017; Salvianolic acid A hydrate; 51622542XO; Dan Phenolic Acid A; Salvianolicacid; MFCD20527310; (2R)-3-(3,4-dihydroxyphenyl)-2-[(E)-3-[2-[(E)-2-(3,4-dihydroxyphenyl)ethenyl]-3,4-dihydroxyphenyl]prop-2-enoyl]oxypropanoic acid; AC1NQZ3H; Dan phenolic acid A hydrate; SCHEMBL19235589; BCP15440; HY-N0318; ZINC4098737; BDBM50414250; MFCD08458447; s9055; AKOS016009674; CCG-269648; DB15246; Salvianolic acid A, analytical standard; (2R)-3-(3,4-dihydroxyphenyl)-2-[(E)-3-[2-[(E)-2-(3,4-dihydroxyphenyl)vinyl]-3,4-dihydroxy-phenyl]prop-2-enoyl]oxy-propanoic acid; AS-75007; CS-0008816; N1803; X1224; C10492; 574S015; Q-100906; Q27108214; UNII-U5TCN455JO component YMGFTDKNIWPMGF-UCPJVGPRSA-N; (2R)-3-(3,4-dihydroxyphenyl)-2-{[(2E)-3-{2-[(1E)-2-(3,4-dihydroxyphenyl)ethenyl]-3,4-dihydroxyphenyl}prop-2-enoyl]oxy}propanoic acid; Benzenepropanoic acid, alpha-((3-(2-(2-(3,4-dihydroxyphenyl)ethenyl)-3,4-dihydroxyphenyl)-1-oxo-2-propenyl)oxy)-3,4-dihydroxy-, (R-(E,E))-
Click to Show/Hide
|
||||
Species Origin | Salvia ... | Click to Show/Hide | |||
Salvia | |||||
Disease | Type 2 diabetes mellitus [ICD-11: 5A11] | Investigative | [1] | ||
Structure |
Click to Download Mol2D MOL |
||||
Click to Show/Hide the Molecular Information and External Link(s) of This Natural Product | |||||
Formula |
C26H22O10
|
||||
PubChem CID | |||||
Canonical SMILES |
C1=CC(=C(C=C1CC(C(=O)O)OC(=O)C=CC2=C(C(=C(C=C2)O)O)C=CC3=CC(=C(C=C3)O)O)O)O
|
||||
InChI |
1S/C26H22O10/c27-18-7-2-14(11-21(18)30)1-6-17-16(4-9-20(29)25(17)33)5-10-24(32)36-23(26(34)35)13-15-3-8-19(28)22(31)12-15/h1-12,23,27-31,33H,13H2,(H,34,35)/b6-1+,10-5+/t23-/m1/s1
|
||||
InChIKey |
YMGFTDKNIWPMGF-UCPJVGPRSA-N
|
||||
CAS Number |
CAS 96574-01-5
|
||||
ChEBI ID | |||||
Herb ID | |||||
SymMap ID | |||||
TCMSP ID |
Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
---|---|---|---|---|---|---|
α. A List of Drug(s) Whose Efficacy can be Enhanced by This NP | ||||||
Latamoxef | Bacterial infection | Click to Show/Hide the Molecular Data of This Drug | ||||
Achieving Therapeutic Synergy | Click to Show/Hide | |||||
Representative Experiment Reporting the Effect of This Combination | [2] | |||||
Detail(s) | Combination Info click to show the detail info of this combination | |||||
In-vivo Model | Ten mice were challenged with 2 * 109 CFU S. aureus. | |||||
Experimental
Result(s) |
The combination of salvianolic acid A with latamoxef completely protects mice against lethal pneumonia caused by methicillin-resistant Staphylococcus aureus. |
Target and Pathway | ||||
---|---|---|---|---|
Target(s) | CDK5 activator 1 (CDK5R1) | Molecule Info | [3] | |
DNA-binding factor KBF1 (p105) | Molecule Info | [4] | ||
Forkhead box protein O3 (FOXO3) | Molecule Info | [5] | ||
Glycogen synthase kinase-3 beta (GSK-3B) | Molecule Info | [3] | ||
Heme oxygenase 1 (HMOX1) | Molecule Info | [6] | ||
Nuclear factor erythroid 2-related factor 2 (Nrf2) | Molecule Info | [6] | ||
BioCyc | Heme degradation | Click to Show/Hide | ||
KEGG Pathway | ErbB signaling pathway | Click to Show/Hide | ||
2 | Chemokine signaling pathway | |||
3 | Cell cycle | |||
4 | PI3K-Akt signaling pathway | |||
5 | Wnt signaling pathway | |||
6 | Hedgehog signaling pathway | |||
7 | Axon guidance | |||
8 | Hippo signaling pathway | |||
9 | Focal adhesion | |||
10 | Signaling pathways regulating pluripotency of stem cells | |||
11 | T cell receptor signaling pathway | |||
12 | B cell receptor signaling pathway | |||
13 | Neurotrophin signaling pathway | |||
14 | Dopaminergic synapse | |||
15 | Insulin signaling pathway | |||
16 | Melanogenesis | |||
17 | Prolactin signaling pathway | |||
18 | Thyroid hormone signaling pathway | |||
19 | Non-alcoholic fatty liver disease (NAFLD) | |||
20 | Alzheimer's disease | |||
21 | Hepatitis C | |||
22 | Measles | |||
23 | Influenza A | |||
24 | HTLV-I infection | |||
25 | Epstein-Barr virus infection | |||
26 | Pathways in cancer | |||
27 | Colorectal cancer | |||
28 | Endometrial cancer | |||
29 | Prostate cancer | |||
30 | Basal cell carcinoma | |||
31 | Protein processing in endoplasmic reticulum | |||
32 | Porphyrin and chlorophyll metabolism | |||
33 | HIF-1 signaling pathway | |||
34 | Mineral absorption | |||
35 | MicroRNAs in cancer | |||
36 | MAPK signaling pathway | |||
37 | Ras signaling pathway | |||
38 | cAMP signaling pathway | |||
39 | NF-kappa B signaling pathway | |||
40 | Sphingolipid signaling pathway | |||
41 | Apoptosis | |||
42 | Osteoclast differentiation | |||
43 | Toll-like receptor signaling pathway | |||
44 | NOD-like receptor signaling pathway | |||
45 | RIG-I-like receptor signaling pathway | |||
46 | Cytosolic DNA-sensing pathway | |||
47 | TNF signaling pathway | |||
48 | Adipocytokine signaling pathway | |||
49 | Cocaine addiction | |||
50 | Epithelial cell signaling in Helicobacter pylori infection | |||
51 | Shigellosis | |||
52 | Salmonella infection | |||
53 | Pertussis | |||
54 | Legionellosis | |||
55 | Leishmaniasis | |||
56 | Chagas disease (American trypanosomiasis) | |||
57 | Toxoplasmosis | |||
58 | Amoebiasis | |||
59 | Tuberculosis | |||
60 | Hepatitis B | |||
61 | Herpes simplex infection | |||
62 | Transcriptional misregulation in cancer | |||
63 | Viral carcinogenesis | |||
64 | Pancreatic cancer | |||
65 | Chronic myeloid leukemia | |||
66 | Acute myeloid leukemia | |||
67 | Small cell lung cancer | |||
68 | Inflammatory bowel disease (IBD) | |||
NetPath Pathway | IL5 Signaling Pathway | Click to Show/Hide | ||
2 | IL1 Signaling Pathway | |||
3 | TCR Signaling Pathway | |||
4 | IL2 Signaling Pathway | |||
5 | TNFalpha Signaling Pathway | |||
6 | Leptin Signaling Pathway | |||
Panther Pathway | Alzheimer disease-presenilin pathway | Click to Show/Hide | ||
2 | Angiogenesis | |||
3 | Cadherin signaling pathway | |||
4 | Hedgehog signaling pathway | |||
5 | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||
6 | Insulin/IGF pathway-protein kinase B signaling cascade | |||
7 | Interleukin signaling pathway | |||
8 | PDGF signaling pathway | |||
9 | PI3 kinase pathway | |||
10 | Wnt signaling pathway | |||
11 | Ras Pathway | |||
12 | CCKR signaling map ST | |||
13 | Apoptosis signaling pathway | |||
14 | T cell activation | |||
Pathwhiz Pathway | Porphyrin Metabolism | Click to Show/Hide | ||
2 | Intracellular Signalling Through Adenosine Receptor A2a and Adenosine | |||
3 | Intracellular Signalling Through Adenosine Receptor A2b and Adenosine | |||
Pathway Interaction Database | LPA receptor mediated events | Click to Show/Hide | ||
2 | Degradation of beta catenin | |||
3 | Reelin signaling pathway | |||
4 | Presenilin action in Notch and Wnt signaling | |||
5 | Integrin-linked kinase signaling | |||
6 | CDC42 signaling events | |||
7 | LKB1 signaling events | |||
8 | Canonical Wnt signaling pathway | |||
9 | Role of Calcineurin-dependent NFAT signaling in lymphocytes | |||
10 | Glucocorticoid receptor regulatory network | |||
11 | C-MYC pathway | |||
12 | Regulation of Androgen receptor activity | |||
13 | BMP receptor signaling | |||
14 | Hedgehog signaling events mediated by Gli proteins | |||
15 | Signaling events mediated by Stem cell factor receptor (c-Kit) | |||
16 | Validated transcriptional targets of deltaNp63 isoforms | |||
17 | Aurora A signaling | |||
18 | Insulin-mediated glucose transport | |||
19 | Class I PI3K signaling events mediated by Akt | |||
20 | p53 pathway | |||
21 | Trk receptor signaling mediated by PI3K and PLC-gamma | |||
22 | Validated transcriptional targets of AP1 family members Fra1 and Fra2 | |||
23 | HIF-1-alpha transcription factor network | |||
24 | Fc-epsilon receptor I signaling in mast cells | |||
25 | BCR signaling pathway | |||
26 | Atypical NF-kappaB pathway | |||
27 | Canonical NF-kappaB pathway | |||
28 | CD40/CD40L signaling | |||
29 | IL12-mediated signaling events | |||
30 | Alternative NF-kappaB pathway | |||
31 | Osteopontin-mediated events | |||
32 | Angiopoietin receptor Tie2-mediated signaling | |||
33 | Signaling events mediated by HDAC Class I | |||
34 | Regulation of Telomerase | |||
35 | IL1-mediated signaling events | |||
36 | TNF receptor signaling pathway | |||
37 | IL2 signaling events mediated by PI3K | |||
38 | Ceramide signaling pathway | |||
39 | amb2 Integrin signaling | |||
40 | IL23-mediated signaling events | |||
41 | HIV-1 Nef: Negative effector of Fas and TNF-alpha | |||
42 | EPO signaling pathway | |||
Reactome | Degradation of beta-catenin by the destruction complex | Click to Show/Hide | ||
2 | AKT phosphorylates targets in the cytosol | |||
3 | Regulation of HSF1-mediated heat shock response | |||
4 | CRMPs in Sema3A signaling | |||
5 | Disassembly of the destruction complex and recruitment of AXIN to the membrane | |||
6 | S33 mutants of beta-catenin aren't phosphorylated | |||
7 | S37 mutants of beta-catenin aren't phosphorylated | |||
8 | S45 mutants of beta-catenin aren't phosphorylated | |||
9 | T41 mutants of beta-catenin aren't phosphorylated | |||
10 | Degradation of GLI2 by the proteasome | |||
11 | Constitutive Signaling by AKT1 E17K in Cancer | |||
12 | Iron uptake and transport | |||
13 | Activation of NF-kappaB in B cells | |||
14 | RIP-mediated NFkB activation via ZBP1 | |||
15 | Regulated proteolysis of p75NTR | |||
16 | NF-kB is activated and signals survival | |||
17 | Senescence-Associated Secretory Phenotype (SASP) | |||
18 | FCERI mediated NF-kB activation | |||
19 | DEx/H-box helicases activate type I IFN and inflammatory cytokines production | |||
20 | Transcriptional regulation of white adipocyte differentiation | |||
21 | TAK1 activates NFkB by phosphorylation and activation of IKKs complex | |||
22 | Interleukin-1 processing | |||
23 | IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) | |||
24 | IkBA variant leads to EDA-ID | |||
25 | CLEC7A (Dectin-1) signaling | |||
26 | CD209 (DC-SIGN) signaling | |||
27 | CLEC7A/inflammasome pathway | |||
28 | MAP3K8 (TPL2)-dependent MAPK1/3 activation | |||
29 | TRAF6 mediated NF-kB activation | |||
WikiPathways | DNA Damage Response (only ATM dependent) | Click to Show/Hide | ||
2 | Senescence and Autophagy in Cancer | |||
3 | Notch Signaling Pathway | |||
4 | Glycogen Metabolism | |||
5 | Insulin Signaling | |||
6 | Wnt Signaling Pathway | |||
7 | Wnt Signaling Pathway and Pluripotency | |||
8 | IL-6 signaling pathway | |||
9 | Wnt Signaling Pathway Netpath | |||
10 | Copper homeostasis | |||
11 | Focal Adhesion | |||
12 | Hair Follicle Development: Induction (Part 1 of 3) | |||
13 | Cardiac Hypertrophic Response | |||
14 | Degradation of beta-catenin by the destruction complex | |||
15 | T-Cell Receptor and Co-stimulatory Signaling | |||
16 | Cardiac Progenitor Differentiation | |||
17 | BDNF signaling pathway | |||
18 | Corticotropin-releasing hormone | |||
19 | B Cell Receptor Signaling Pathway | |||
20 | IL17 signaling pathway | |||
21 | Neural Crest Differentiation | |||
22 | Alzheimers Disease | |||
23 | IL-7 Signaling Pathway | |||
24 | Regulation of Microtubule Cytoskeleton | |||
25 | TWEAK Signaling Pathway | |||
26 | Leptin signaling pathway | |||
27 | Semaphorin interactions | |||
28 | Cell Cycle | |||
29 | MicroRNAs in cardiomyocyte hypertrophy | |||
30 | Androgen receptor signaling pathway | |||
31 | IL-5 Signaling Pathway | |||
32 | Oxidative Stress | |||
33 | Transcriptional activation by NRF2 | |||
34 | NRF2 pathway | |||
35 | Nuclear Receptors Meta-Pathway | |||
36 | Aryl Hydrocarbon Receptor Pathway | |||
37 | Mesodermal Commitment Pathway | |||
38 | Aryl Hydrocarbon Receptor | |||
39 | Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis | |||
40 | Arylhydrocarbon receptor (AhR) signaling pathway | |||
41 | miR-targeted genes in squamous cell - TarBase | |||
42 | miR-targeted genes in muscle cell - TarBase | |||
43 | miR-targeted genes in lymphocytes - TarBase | |||
44 | miR-targeted genes in leukocytes - TarBase | |||
45 | miR-targeted genes in epithelium - TarBase | |||
46 | Toll-like receptor signaling pathway | |||
47 | SIDS Susceptibility Pathways | |||
48 | TCR Signaling Pathway | |||
49 | TGF Beta Signaling Pathway | |||
50 | IL-4 Signaling Pathway | |||
51 | Apoptosis Modulation by HSP70 | |||
52 | MAPK Signaling Pathway | |||
53 | Myometrial Relaxation and Contraction Pathways | |||
54 | IL1 and megakaryotyces in obesity | |||
55 | Apoptosis-related network due to altered Notch3 in ovarian cancer | |||
56 | Hair Follicle Development: Cytodifferentiation (Part 3 of 3) | |||
57 | Hair Follicle Development: Organogenesis (Part 2 of 3) | |||
58 | Selenium Metabolism and Selenoproteins | |||
59 | Cytosolic sensors of pathogen-associated DNA | |||
60 | Fc epsilon receptor (FCERI) signaling | |||
61 | Transcriptional Regulation of White Adipocyte Differentiation | |||
62 | Signaling by the B Cell Receptor (BCR) | |||
63 | TAK1 activates NFkB by phosphorylation and activation of IKKs complex | |||
64 | Structural Pathway of Interleukin 1 (IL-1) | |||
65 | EBV LMP1 signaling | |||
66 | Apoptosis | |||
67 | Integrated Pancreatic Cancer Pathway | |||
68 | Oncostatin M Signaling Pathway | |||
69 | AGE/RAGE pathway | |||
70 | TNF alpha Signaling Pathway | |||
71 | TSLP Signaling Pathway | |||
72 | RANKL/RANK Signaling Pathway | |||
73 | Integrated Breast Cancer Pathway | |||
74 | Signalling by NGF | |||
75 | IL-1 signaling pathway | |||
76 | TCR signaling | |||
77 | RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways | |||
78 | Interleukin-1 signaling | |||
79 | Interleukin-1 processing | |||
80 | Apoptosis Modulation and Signaling | |||
81 | Folate Metabolism | |||
82 | TFs Regulate miRNAs related to cardiac hypertrophy | |||
83 | Vitamin B12 Metabolism | |||
84 | Selenium Micronutrient Network | |||
85 | Regulation of toll-like receptor signaling pathway | |||
86 | Osteopontin Signaling |